| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM |
| ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| SPECIAL FEATURES | LORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG /ML; FILL VOLUME: 1 ML; UNIT SIZE: 1 ML; STORE IN REFRIGERATOR 2 TO 8 C (36 TO 46 F); PROTECT FROM LIGHT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |